{"id":10268,"date":"2018-04-30T12:48:09","date_gmt":"2018-04-30T16:48:09","guid":{"rendered":"https:\/\/medicarereport.org\/?p=10268"},"modified":"2018-04-30T12:48:09","modified_gmt":"2018-04-30T16:48:09","slug":"how-a-drug-company-under-pressure-for-high-prices-ratchets-up-political-activity","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=10268","title":{"rendered":"How A Drug Company Under Pressure For High Prices Ratchets Up Political Activity"},"content":{"rendered":"<p>(By Jay Hancock and Elizabeth Lucas for Kaiser Health News)<\/p>\n<p><span style=\"color: #333333; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'PT Serif', Georgia, serif; font-size: 18px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;\">Business looked challenging for Novo Nordisk at the end of 2016. As pressure mounted over the pharma giant\u2019s soaring insulin prices, investors drove its stock down by a third on fears that policymakers would take action, limit prices and hurt profits. <a href=\"https:\/\/khn.org\/news\/how-a-drug-company-under-pressure-for-high-prices-ratchets-up-political-activity\/?utm_campaign=KHN%3A%20First%20Edition&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=62522063&amp;_hsenc=p2ANqtz-8UsUJV-WEPQi9AMD_vnmPrOP7MTu0wagYI4-oTuSH-qbIr1x_FSsCEjIgB2OEUoMWCMiVY-GGUp9NgY5VWMqJHLs6FBw&amp;_hsmi=62522063\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p style=\"margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; line-height: 1.6; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', serif; font-size: 15px; font-style: normal; font-weight: 400; word-spacing: 0px; vertical-align: baseline; white-space: normal; orphans: 2; widows: 2; font-stretch: inherit; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-numeric: inherit; font-variant-east-asian: inherit;\">Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n<p style=\"margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; line-height: 1.6; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', serif; font-size: 15px; font-style: normal; font-weight: 400; word-spacing: 0px; vertical-align: baseline; white-space: normal; orphans: 2; widows: 2; font-stretch: inherit; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-numeric: inherit; font-variant-east-asian: inherit;\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-899\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png\" sizes=\"auto, (max-width: 129px) 100vw, 129px\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-1024x533.png 1024w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-390x205.png 390w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png 1600w\" alt=\"\" width=\"129\" height=\"67\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Jay Hancock and Elizabeth Lucas for Kaiser Health News) Business looked challenging for Novo Nordisk at the end of<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-10268","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10268"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10268\/revisions"}],"predecessor-version":[{"id":10269,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10268\/revisions\/10269"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}